Hvid-Jensen, F <br/><br/>
Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus--authors' reply.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Oct 2014 
 - 860-1 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/apt.12931  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--prevention & control<br/>Barrett Esophagus--drug therapy<br/>Esophageal Neoplasms--prevention & control<br/>Esophagus--pathology<br/>Female<br/>Humans<br/>Male<br/>Proton Pump Inhibitors--therapeutic use